Program: Opening remarks: Thomas Farrington, PHEN President & Founder

Slides:



Advertisements
Similar presentations
Napa Valley Oncology Nursing Society From CHIP to Successful Chapter Karen Stilwell MSN RN CNS OCN November 19, 2012.
Advertisements

Remarks: Thomas A. Farrington, PHEN President and Founder Guest Speaker: Arthur L. Burnett, II, M.D., MBA Professor of Urology Director, Sexual Medicine.
Program: 2011 PHEN Summit: An Overview. Partners Dr. Ed Benz- President Ms. Anne Levine- Vice President of External Affairs Ms. Magnolia Contreras-
CI-1 Update on the Safety of Erythropoietin Products in Patients With Cancer May 4, 2004 Robert DeLap, MD, PhD Vice President, Global Regulatory Affairs.
Program: Opening remarks: Thomas Farrington, PHEN President & Founder Featured Speakers: PHEN Survivor Network Action Panel.
January 11 th, 2012: Opening Remarks: Thomas Farrington, PHEN President & Founder & Jacques Carter, MD, Dana Farber Cancer Institute Featured Speaker:
2 nd Annual Prostate Cancer Forum September 22, 2012 Charles H. Wright Museum of African American History Detroit, MI Welcome Please Check in for continuing.
1 COMBIDEX ® (ferumoxtran-10). Introduction, Combidex, Indication Mark Roessel Vice President Regulatory Affairs, Advanced Magnetics, Inc.
Speaker: Thomas A. Farrington, President and Founder, PHEN Remarks: Mark Kennedy, MBA, Senior Consultant, PHEN Why Knowledge is the Best Defense Against.
MISCELLANEOUS Cost of Program Meetings Guests: $40.00 Retired & Life Retired: $30.00 Prospective Members: Free Please return your reservation card or reply.
PHEN Church Partnerships “Joining Hands in Prayer and Action to Save Lives” Annual “Father’s Day Rally Against Prostate Cancer” The Rally takes place.
Guest Speaker: Richard JaeBong (Rick) Lee, MD, PhD Assistant Physician, Department of Medicine Massachusetts General Hospital Remarks: Mr. Mark Kennedy,
CI-1 Tarceva ® (erlotinib) Tablets in Combination with Gemcitabine as a 1st-line Treatment of Pancreatic Cancer Presentation to the Oncologic Drugs Advisory.
Speakers: Mr. Mark W. Kennedy, MBA PHEN Director of Outreach Kimberly R. Rogers, Ph.D. PHEN Director of Education Programs PHEN’s Education and Community.
A 1 Closing Remarks C. Elaine Jones, Ph.D Vice President Respiratory Regulatory Affairs.
Dana-Farber Cancer Institute (DFCI) and Prostate Health Education Network (PHEN) Partnership to Eliminate Prostate Cancer Disparities Edward J. Benz, Jr.,
“The Impact of Diet and Nutrition on Prostate Cancer” Remarks: Thomas A. Farrington, PHEN President and Founder Guest Speaker: Hillary M. Wright, MEd,
Speakers: Thomas A. Farrington President and Founder, PHEN J. Jacques Carter, M.D., MPH Associate Professor Harvard Medical School Mark W. Kennedy, MBA.
February 8th, 2012: Opening Remarks: Thomas Farrington, PHEN President & Founder Featured Speaker: Paul L. Nguyen, MD, Dana Farber Cancer Institute Clinical.
CI-1 Lenalidomide Myelodysplastic Syndromes (Revlimid ®, CC-5013, CDC-501) Graham Burton, MD Senior Vice President Regulatory Affairs Celgene Corporation.
NAESB WEQ/WGQ FERC Forms Subcommittee Example XML April 19, 2016 Information On Formula Rates Important Changes During The Quarter Or Year.
Presented By: Eunice (Robbie) Robinson PHEN Survivor Network Support Group Leader.
2013 BRIGHT FUTURES PRIZE TAKING CONTROL OF EPILEPSY: Designing a lab-on-a-chip UTKAN DEMIRCI, PHD STUCK ON YOU:The next-generation adhesive JEFF KARP,
The Use of Milnacipran in Treating Fibromyalgia. MilnacipranMilnacipran, also known as milnacipran hydrochloride or Savella, helps to alleviate the pain.
A.C.T.S. OF F.A.I.T.H. APHA Annual Meeting 11/04/15 Marie Rule Gilliam, Executive Director.
Special Seminar Series
"Prostate Cancer And Sexual Health - Understanding History
“Knowledge is the Best Defense Against Prostate Cancer”
Keynote Speaker: John Condeelis, PhD
Founder & President The Prostate Net
PHEN Clinical Trials Rally
“Knowledge is the Best Defense Against Prostate Cancer”
What Are Clinical Trials?
Welcome to the November 14, 2012 CPI meeting
Jack Kavanaugh Chairman of the board, CEO and Co-founder of several technologies driven Companies.
Prostate Cancer Awareness Month
Challenges of Cancer in Vermont and Rural Northern New England
Program: Opening remarks: Thomas Farrington, PHEN President & Founder
Telemedicine Specialty Support Promotes Hepatitis C Treatment by Primary Care Providers in the Department of Veterans Affairs  Lauren A. Beste, MD, MSc,
July 11th, 2012: Featured Speaker: Jacques Carter, MD, Dana Farber Cancer Institute Clinical Trial: Mark Kennedy, Dana Farber Cancer Institute.
April 10th, 2013 “Knowledge is the Best Defense Against Prostate Cancer” Presenter: Thomas A. Farrington, PHEN President and Founder.
Webcast: Today at 6:00pm ET
Telemedicine Specialty Support Promotes Hepatitis C Treatment by Primary Care Providers in the Department of Veterans Affairs  Lauren A. Beste, MD, MSc,
Preface Physical Medicine and Rehabilitation Clinics
Prostate Cancer: Breaking The Silence
“Knowledge is the Best Defense Against Prostate Cancer”
MP57-17 CAN PROSTATIC SPECIFIC ANTIGEN VELOCITY (PSAV) IMPROVE THE DIAGNOSTIC ACCURACY OF PROSTATE IMAGING REPORTING AND DATA SYSTEM (PI-RADS) SCORE.
PSA test is best at predicting lethal prostate cancer
Ashley J. Stevens, D.Phil (Oxon), CLP, RTTP
Paraneoplastic and Cancer Treatment-Related Rheumatic Disorders
Cancer Disparities Research Symposium
Prostate Cancer Clinical Trial Opportunities:
Using Animated Computer-generated Text and Graphics to Depict the Risks and Benefits of Medical Treatment  Alan R. Tait, PhD, Terri Voepel-Lewis, MSN,
Trends and Racial Differences in the Use of Androgen Deprivation Therapy for Metastatic Prostate Cancer  April P. Carson, PhD, Daniel L. Howard, PhD,
Preface Clinics in Sports Medicine
Phase II Trial of Paclitaxel and Cisplatin in Patients with Extensive Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Trial 9430  Thomas E.
Looking Back: Cancer Stem Cells
Clinical Trials and Black History-Shaping a Brighter Future
“Managing Prostate Cancer Survivorship”
Preparing for the Future
February 13th , 2013: Prostate Cancer Survivors
2017 Budget Development Plan for External Affairs
Volume 55, Issue 1, Pages (January 1999)
February 8th, 2012: Opening Remarks: Thomas Farrington, PHEN President & Founder Jacques Carter, MD, Dana Farber Cancer Institute Featured Speaker: Paul.
The Impact of Vitamin D, Statins, and Nutrition on Prostate Cancer
Program: Opening remarks: Thomas Farrington, PHEN President & Founder
October 10th, 2012: Remarks: Robbie Robinson, PHEN Survivor Network Member Presenter: H. Jeffrey Lawrence, MD, Genomic Health.
Webcast: Today at 6:00pm ET
Looking Back: Cancer Stem Cells
Presentation transcript:

Program: Opening remarks: Thomas Farrington, PHEN President & Founder Featured Speaker: Sharon Bober, Ph.D. Androgen Deprivation Treatment: Jacques Carter, M.D.

Partners Dr. Ed Benz- President Ms. Anne Levine- Vice President of External Affairs Ms. Magnolia Contreras- Director Community Benefits Ms. Athene Wilson Glover- Community Benefits Mr. Mark Kennedy- Community Benefits

PHEN Rally Against Prostate Cancer Sponsors Dana Farber Cancer Centocor Ortho Institute Biotech Inc. Roswell Park Cancer Accuracy Institute CyberKnife Dendreon Medivation Ferring Pharmaceuticals Takeda Millenium Genentech BN Immuno Therapeutics US HIFU State Street Bank of America/Merrill Lynch : Perpetual Trust for Charitable Giving

April Program April 13th Towards Personalized Medicine for Prostate Cancer Guest Speaker: Dr. Levi Garraway Treatment Options Dr. Jacques Carter

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.